Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
24°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Wuhan General Group [China] Inc
(OP:
WUHN
)
0.0002
UNCHANGED
Last Price
Updated: 10:44 AM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0002
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0002
Today's Range
0.0002 - 0.0002
52wk Range
0.0001 - 0.0002
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wuhan General Group China Announces Corporate Update
May 17, 2022
CAPE TOWN, SA / ACCESSWIRE / May 17, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health...
From
Wuhan General Group, Inc.
Via
AccessWire
Dr AnnaRx Announces Rob Simbowe CBD Muscle and Joint Rubs
March 30, 2022
CAPE TOWN, SA / ACCESSWIRE / March 30, 2022 / WUHAN GENERAL GROUP, INC. (WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health...
From
Wuhan General Group, Inc.
Via
AccessWire
Performance
YTD
+100.00%
+100.00%
1 Month
+100.00%
+100.00%
3 Month
+100.00%
+100.00%
6 Month
+100.00%
+100.00%
1 Year
+100.00%
+100.00%
More News
Read More
Medspresso and Liviana Carried by 100 Independent South African Retailers
March 28, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
M2Bio Sciences Attending Master Investor Show in London, UK
March 16, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
M2Bio Labs Offers Ketamine IV & Personalized Supercharged Vitamin IV Drip
March 10, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
Medspresso Joins the Speciality Coffee Association of South Africa
February 28, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
Medspresso Launches CBD and Functional Mushroom Single Serve Sachets
February 01, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
Wuhan General Group Launches Mental Illness Drug Discovery Company Neurai Life Sciences
January 19, 2022
From
Wuhan General Group, Inc.
Via
AccessWire
M2Bio Rolls Out Sustainable Packaging for Liviana
December 31, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
M2Bio Director of Health and Fitness Rob Simbowe Visits Zambia and Hosts Vulnerable Youth Symposium
December 16, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Wuhan Acquires Remaining Shares in Tsime
December 08, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Medspresso Coffee Webinar Now Available for Viewing
December 07, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Wuhan General Group Inc Cancels 5,000,000 Common Shares
November 22, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
The New Multi Capsule "Medspresso Torro" Gets Unleashed
November 04, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee
November 01, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
M2Bio Building A World Class Supply Chain Solution - Dr. Southey and Dr. Zarrebini Update on M2Bio Blockchain and Technology Group
October 25, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Via
Benzinga
The Future Of Personalized Medicine For Mental Illness by Dr. Riyad Domingo
September 23, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Via
Benzinga
Medspresso Announces Additional Speciality Coffees To The Range
September 17, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Exposures
COVID-19
M2Bio Sciences Appoints Dr. Riyad Domingo as Chief Innovation Officer
September 02, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Topics
Derivatives
Exposures
Derivatives
Product Safety
Dr. AnnaRx(TM) Launching CBD & CBN Nutraceutical Line
August 24, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Dr. Southey and Dr. Zarrebini Join M2Bio Sciences and Establish M2Bio Blockchain Research and Technology Group
August 19, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Topics
Economy
Exposures
Economy
Wuhan General Group Launches M2Bio Labs in Hout Bay, South Africa
August 16, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Wuhan General Group Updates on Third Scientific Paper Published on Psychedelics
August 05, 2021
From
Wuhan General Group, Inc.
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
